• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过烯醇-乌吉/还原/环化序列合成色烯并[3,4-]哌嗪。

Synthesis of Chromeno[3,4-]piperazines by an Enol-Ugi/Reduction/Cyclization Sequence.

机构信息

Laboratory of Bioorganic Chemistry & Membrane Biophysics (L.O.B.O.), Department of Organic and Inorganic Chemistry, University of Extremadura, 10003 Cáceres, Spain.

出版信息

Molecules. 2021 Feb 27;26(5):1287. doi: 10.3390/molecules26051287.

DOI:10.3390/molecules26051287
PMID:33673443
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7956738/
Abstract

Keto piperazines and aminocoumarins are privileged building blocks for the construction of geometrically constrained peptides and therefore valuable structures in drug discovery. Combining these two heterocycles provides unique rigid polycyclic peptidomimetics with drug-like properties including many points of diversity that could be modulated to interact with different biological receptors. This work describes an efficient multicomponent approach to condensed chromenopiperazines based on the novel enol-Ugi reaction. Importantly, this strategy involves the first reported post-condensation transformation of an enol-Ugi adduct.

摘要

酮哌嗪和氨基香豆素是构建几何约束肽的重要结构单元,因此在药物发现中是有价值的结构。将这两种杂环组合在一起,可以提供独特的刚性多环肽类似物,具有类药性,包括许多可以调节的多样性,以与不同的生物受体相互作用。这项工作描述了一种基于新型烯醇-Ugi 反应的稠合色满哌嗪的高效多组分方法。重要的是,该策略涉及烯醇-Ugi 加合物的首次报道的缩合后转化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0437/7956738/5cc6227eda80/molecules-26-01287-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0437/7956738/a1a6cf346c5d/molecules-26-01287-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0437/7956738/70aec653e4aa/molecules-26-01287-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0437/7956738/442ee4b558d0/molecules-26-01287-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0437/7956738/52c35a172408/molecules-26-01287-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0437/7956738/c468c8c4b4df/molecules-26-01287-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0437/7956738/5cc6227eda80/molecules-26-01287-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0437/7956738/a1a6cf346c5d/molecules-26-01287-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0437/7956738/70aec653e4aa/molecules-26-01287-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0437/7956738/442ee4b558d0/molecules-26-01287-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0437/7956738/52c35a172408/molecules-26-01287-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0437/7956738/c468c8c4b4df/molecules-26-01287-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0437/7956738/5cc6227eda80/molecules-26-01287-sch004.jpg

相似文献

1
Synthesis of Chromeno[3,4-]piperazines by an Enol-Ugi/Reduction/Cyclization Sequence.通过烯醇-乌吉/还原/环化序列合成色烯并[3,4-]哌嗪。
Molecules. 2021 Feb 27;26(5):1287. doi: 10.3390/molecules26051287.
2
Exploitation of the Ugi-Joullié reaction in drug discovery and development.药物发现与开发中 Ugi-Joullié 反应的应用。
Expert Opin Drug Discov. 2019 Jul;14(7):639-652. doi: 10.1080/17460441.2019.1604676. Epub 2019 Apr 19.
3
Coupling Interrupted Fischer and Multicomponent Joullié-Ugi to Chase Chemical Diversity: from Batch to Sustainable Flow Synthesis of Peptidomimetics.耦合中断的 Fischer 和多组分 Joullié-Ugi 反应以追求化学多样性:从批量到可持续流动合成肽模拟物。
ChemMedChem. 2021 Dec 14;16(24):3795-3809. doi: 10.1002/cmdc.202100474. Epub 2021 Oct 18.
4
Post-Ugi Cyclization for the Construction of Diverse Heterocyclic Compounds: Recent Updates.用于构建多种杂环化合物的乌吉反应后环化:最新进展
Front Chem. 2018 Nov 20;6:557. doi: 10.3389/fchem.2018.00557. eCollection 2018.
5
Recent Advances in the Synthesis of Peptidomimetics via Ugi Reactions.通过乌吉反应合成拟肽的最新进展。
Chemistry. 2024 Mar 7;30(14):e202303597. doi: 10.1002/chem.202303597. Epub 2024 Jan 10.
6
Synthesis of macrocyclic peptidomimetics via the Ugi-click-strategy.通过 Ugi-click 策略合成大环肽模拟物。
Org Biomol Chem. 2019 Mar 27;17(13):3433-3445. doi: 10.1039/c9ob00229d.
7
Isocyanide-based multicomponent reactions towards cyclic constrained peptidomimetics.基于异氰化物的多组分反应合成环状约束肽类似物。
Beilstein J Org Chem. 2014 Mar 4;10:544-98. doi: 10.3762/bjoc.10.50. eCollection 2014.
8
Application of the Ugi reaction with multiple amino acid-derived components: synthesis and conformational evaluation of piperazine-based minimalist peptidomimetics.含多个氨基酸衍生成分的乌吉反应的应用:基于哌嗪的极简拟肽的合成与构象评估
Org Biomol Chem. 2015 May 7;13(17):4993-5005. doi: 10.1039/c5ob00218d.
9
Synthesis of polyhydroxylated piperidine and pyrrolidine peptidomimetics via one-pot sequential lactam reduction/Joullié-Ugi reaction.通过一锅法连续内酰胺还原/朱利耶-乌吉反应合成多羟基化哌啶和吡咯烷类肽模拟物。
J Org Chem. 2015 Apr 3;80(7):3621-33. doi: 10.1021/acs.joc.5b00335. Epub 2015 Mar 24.
10
Amide-derived enols in enol-Ugi reactions: expanding horizons for peptidomimetic scaffold synthesis.烯醇-乌吉反应中酰胺衍生的烯醇:拓展拟肽支架合成的视野
Org Biomol Chem. 2024 Oct 23;22(41):8300-8309. doi: 10.1039/d4ob01216j.

引用本文的文献

1
Unlocking Enol-Ugi-Derived Conformationally Restricted Peptidomimetic Motifs.解锁烯醇 - 乌吉反应衍生的构象受限拟肽基序。
J Org Chem. 2025 Mar 28;90(12):4382-4388. doi: 10.1021/acs.joc.5c00229. Epub 2025 Mar 13.
2
Stefano Marcaccini: a pioneer in isocyanide chemistry.斯特凡诺·马尔卡奇尼:异腈化学的先驱。
Mol Divers. 2024 Feb;28(1):335-418. doi: 10.1007/s11030-023-10641-7. Epub 2023 Apr 12.

本文引用的文献

1
Coumarin-piperazine derivatives as biologically active compounds.香豆素-哌嗪衍生物作为生物活性化合物。
Saudi Pharm J. 2020 Feb;28(2):220-232. doi: 10.1016/j.jsps.2019.11.025. Epub 2019 Dec 7.
2
Novel electrophilic amides amenable by the Ugi reaction perturb thioredoxin system via thioredoxin reductase 1 (TrxR1) inhibition: Identification of DVD-445 as a new lead compound for anticancer therapy.新型亲电酰胺可通过 Ugi 反应干扰硫氧还蛋白系统,抑制硫氧还蛋白还原酶 1(TrxR1):鉴定 DVD-445 为癌症治疗的新先导化合物。
Eur J Med Chem. 2019 Nov 1;181:111580. doi: 10.1016/j.ejmech.2019.111580. Epub 2019 Aug 1.
3
Application of Silver Nanoparticles in the Multicomponent Reaction Domain: A Combined Catalytic Reduction Methodology to Efficiently Access Potential Hypertension or Inflammation Inhibitors.
银纳米颗粒在多组分反应领域的应用:一种高效获取潜在高血压或炎症抑制剂的联合催化还原方法。
ACS Omega. 2018 Nov 30;3(11):16005-16013. doi: 10.1021/acsomega.8b02749. Epub 2018 Nov 27.
4
Experimental Evidence of the Antitumor, Antimetastatic and Antiangiogenic Activity of Ellagic Acid.鞣花酸的抗肿瘤、抗转移和抗血管生成活性的实验证据。
Nutrients. 2018 Nov 14;10(11):1756. doi: 10.3390/nu10111756.
5
The promiscuous estrogen receptor: Evolution of physiological estrogens and response to phytochemicals and endocrine disruptors.混杂的雌激素受体:生理雌激素的演化以及对植物化学物质和内分泌干扰物的反应。
J Steroid Biochem Mol Biol. 2018 Nov;184:29-37. doi: 10.1016/j.jsbmb.2018.07.001. Epub 2018 Jul 20.
6
Bicyclic Piperazine Mimetics of the Peptide β-Turn Assembled via the Castagnoli-Cushman Reaction.通过 Castagnoli-Cushman 反应构建的肽 β-转角模拟双环哌嗪。
J Org Chem. 2018 May 18;83(10):5859-5868. doi: 10.1021/acs.joc.8b00811. Epub 2018 May 3.
7
Identification of Inhibitors of CD36-Amyloid Beta Binding as Potential Agents for Alzheimer's Disease.鉴定CD36与β淀粉样蛋白结合的抑制剂作为阿尔茨海默病的潜在药物
ACS Chem Neurosci. 2017 Jun 21;8(6):1232-1241. doi: 10.1021/acschemneuro.6b00386. Epub 2017 Feb 15.
8
Cytotoxicity and Mechanism of Action of the Marine-Derived Fungal Metabolite Trichodermamide B and Synthetic Analogues.海洋来源真菌代谢产物木霉酰胺B及其合成类似物的细胞毒性与作用机制
J Nat Prod. 2017 Mar 24;80(3):676-683. doi: 10.1021/acs.jnatprod.6b00963. Epub 2017 Jan 4.
9
A new species of Trichoderma hypoxylon harbours abundant secondary metabolites.一个新的Hypoxylon 木霉种蕴藏着丰富的次生代谢产物。
Sci Rep. 2016 Nov 21;6:37369. doi: 10.1038/srep37369.
10
Neo-tanshinlactone selectively inhibits the proliferation of estrogen receptor positive breast cancer cells through transcriptional down-regulation of estrogen receptor alpha.新丹参内酯通过转录下调雌激素受体α选择性抑制雌激素受体阳性乳腺癌细胞的增殖。
Pharmacol Res. 2016 Sep;111:849-858. doi: 10.1016/j.phrs.2016.07.044. Epub 2016 Aug 1.